Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
The use of D-dimer in specific clinical conditions: A narrative review
European Journal of Internal Medicine , 09/02/09
Bruinstroop E et al. – It is safe to use D–dimer testing in combination with a clinical decision rule in patients of all ages, patients presenting with a suspected recurrent venous thromboembolism or inpatients with suspected pulmonary embolism. As patients with recurrent venous thromboembolism, elderly patients and inpatients have higher levels of D–dimer, D–dimer testing has a low specificity and the need for additional radiological testing is increased.
Related Articles
Performance of two relatively new quantitative D-dimer assays (Innovance D-dimer and AxSYM D-dimer) for the exclusion of deep vein thrombosis
Thrombosis Research, 11/25/09
Relevance Score: 87%
D-dimer as a possible prognostic marker of operable hormone receptor-negative breast cancer
Annals of Oncology, 11/04/09
Relevance Score: 82%
Elevated plasma fibrin D-dimer as a risk factor for vascular dementia: the Three-City cohort study
Journal of Thrombosis and Haemostasis, 11/30/09
Relevance Score: 80%
Elevated D-dimer Level in the Differential Diagnosis of Venous Malformations
Archives of Dermatology, 11/17/09
Relevance Score: 80%
D-Dimers Predict Stroke Subtype when Assessed Early
Cerebrovascular Diseases, 11/16/09
Relevance Score: 80%
Today in CV/Thromboembolic...keeping you current
Receive free subspecialty "5-minute updates" via email
The clinical course of pulmonary embolism patients anticoagulated for 1 year: results of a prospective, observational, cohort study
Journal of Thrombosis and Haemostasis, 12/18/09
Volumetric or time-based capnography for excluding pulmonary embolism in outpatients
Journal of Thrombosis and Haemostasis, 12/18/09
Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil
Rheumatology, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


